Malta - Tiếng Anh - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - diphtheria toxoid, tetanus toxoid, bordetella pertussis, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate - powder for suspension for injection - diphtheria toxoid 30 iu tetanus toxoid 40 iu bordetella pertussis 30 iu pertussis toxoid 25 µg filamentous haemagglutinin (fha) 25 µg pertactin 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg - vaccines

Bahrain - Tiếng Anh - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - pt +fha+69k +dt +tt - suspension for injection

Bahrain - Tiếng Anh - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - dtpa-hbv-ipv/hib - powder and suspension for injection

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

glaxosmithkline philippines inc. - diphtheria, tetanus and pertussis (acellular component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension for injection (im) (preservative-free)

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - tetanus toxoid; pertussis antigens; human poliovirus type 3 inactivated; human poliovirus type 2 inactivated; human poliovirus type 1 inactivated; hepatitis b virus surface antigen; haemophilus influenzae type b polysaccharide protein conjugate; diphtheria toxoid - powder and suspension for suspension for injection

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - combined diphtheria, tetanus and acellular pertussis, hepatitis b, inactivated poliomyelitis and haemophilus influenzae type b vaccine (preservative-free) - suspension for injection (i.m.)

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - neisseria meningitidis c tetanus toxoid - suspension for injection

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - pertussis toxoid, quantity: 16 microgram/ml; pertussis filamentous haemagglutinin, quantity: 16 microgram/ml; pertactin, quantity: 5 microgram/ml; diphtheria toxoid, quantity: 4 iu/ml; tetanus toxoid, quantity: 40 iu/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; aluminium phosphate; sodium chloride; water for injections - boostrix is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals aged four years and older (see section 4.2 dose and method of administration).,boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy (see section 4.2 dose and method of administration, section 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties).,the use of boostrix should be in accordance with official recommendations.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - pertussis toxoid, quantity: 16 microgram/ml; tetanus toxoid, quantity: 40 iu/ml; diphtheria toxoid, quantity: 4 iu/ml; pertactin, quantity: 5 microgram/ml; pertussis filamentous haemagglutinin, quantity: 16 microgram/ml - injection, suspension - excipient ingredients: water for injections; aluminium hydroxide hydrate; aluminium phosphate; sodium chloride - boostrix is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals aged four years and older (see section 4.2 dose and method of administration).,boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy (see section 4.2 dose and method of administration, section 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties).,the use of boostrix should be in accordance with official recommendations.

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - diphtheria toxoid; filamentous hemagglutinin (fha); inactivated polio virus type 1; inactivated polio virus type 2; inactivated polio virus type 3; pertactin (prn); pertussis toxoid (pt); tetanus toxoid - injection, suspension - diphtheria toxoid 2.5 lf/ 0.5 ml - not less than 2 iu; filamentous hemagglutinin (fha) 8 mcg/0.5ml; inactivated polio virus type 1 40 du/0.5 ml; inactivated polio virus type 2 8 du/0.5 ml; inactivated polio virus type 3 32 du/0.5 ml; pertactin (prn) 2.5 mcg/0.5 ml; pertussis toxoid (pt) 8 mcg/0.5 ml; tetanus toxoid 5.0 lf/0.5ml - not less than 20 iu